Krishna Kodukula
Affiliations: | ShangPharma Innovation and Stanford Research Institute |
Google:
"Krishna Kodukula"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moos WH, Faller DV, Glavas IP, et al. (2023) Epilepsy: Mitochondrial Connections to the 'Sacred' Disease. Mitochondrion |
| Moos WH, Faller DV, Glavas IP, et al. (2022) Treatment and Prevention of Pathological Mitochondrial Dysfunction in Retinal Degeneration and in Photoreceptor Injury. Biochemical Pharmacology. 115168 |
| Moos WH, Faller DV, Glavas IP, et al. (2021) Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochemical Pharmacology. 193: 114809 |
| Moos WH, Faller DV, Glavas IP, et al. (2020) Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Bioresearch Open Access. 9: 94-105 |
| Moos WH, Faller DV, Glavas IP, et al. (2019) Epigenetic treatment of dermatologic disorders Drug Development Research. 80: 702-713 |
| Moos WH, Faller DV, Glavas IP, et al. (2018) A New Approach to Treating Neurodegenerative Otologic Disorders. Bioresearch Open Access. 7: 107-115 |
| Moos WH, Faller DV, Glavas IP, et al. (2017) Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Bioresearch Open Access. 6: 169-181 |
| Kodukula K, Faller DV, Harpp DN, et al. (2017) Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. Bioresearch Open Access. 6: 123-132 |
| Moos WH, Pinkert CA, Irwin MH, et al. (2016) Epigenetic Treatment of Persistent Viral Infections. Drug Development Research |
| Anderson DC, Kodukula K. (2014) Biomarkers in pharmacology and drug discovery. Biochemical Pharmacology. 87: 172-88 |